[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
May 1968

Scintiscanning in Malignant Lymphomatous Involvement of Bone

Author Affiliations

USA; USA, Denver

From the Department of Medicine, Fitzsimons General Hospital, Denver. Doctor Weber is now with the Department of Medicine, DeWitt Army Hospital, Fort Belvoir, Va; Dr. DeNardo is now with the Department of Nuclear Medicine, Veterans Administration Hospital, Palo Alto, Calif; and Dr. Bergin is with the Department of Medicine, Fitzsimons General Hospital and the University of Colorado School of Medicine, Denver.

Arch Intern Med. 1968;121(5):433-437. doi:10.1001/archinte.1968.03640050043009

The reported radiographic and autopsy incidence of lymphomatous involvement of bone has been reviewed. Results of 19 patients with malignant lymphoma studied with bone scintiscans and roentgenograms are presented. Scintiscans were positive in 84.2% of the patients and roentgenograms were positive in only 10.5%. Bone marrow biopsy was positive in only three out of 16 cases. Necropsy material obtained from vertebral bones which were positive on scanning revealed histological evidence of disease in all the six cases. The scintiscan is an excellent means of evaluating early lymphomatous involvement of bone and the incidence in relatively asymptomatic patients is probably much greater than can be appreciated roentgenographically or suspected clinically. The early detection of osseous involvement may be an important guide to therapy.